McDaniel Terry & Co
- SEC CIK
- 0001104366
- Latest filing
- Jul 30, 2026
ABBV holding history
AbbVie Inc. in every 13F filed by McDaniel Terry & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings
- Shares (Q2 2026)
- 12,069
- Value
- $3.04M
- % of portfolio
- 0.2%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 12,069 | $3.04M | 0.2% | +10+0.1% | Added | Holders |
| Q1 2026 | 12,059 | $2.62M | 0.2% | +1,009+9.1% | Added | Holders |
| Q4 2025 | 11,050 | $2.52M | 0.2% | −3,192−22.4% | Reduced | Holders |
| Q3 2025 | 14,242 | $3.30M | 0.3% | −40−0.3% | Reduced | Holders |
| Q2 2025 | 14,282 | $2.65M | 0.2% | −89−0.6% | Reduced | Holders |
| Q1 2025 | 14,371 | $3.01M | 0.3% | −134−0.9% | Reduced | Holders |
| Q4 2024 | 14,505 | $2.58M | 0.2% | −20.0% | Reduced | Holders |
| Q3 2024 | 14,507 | $2.87M | 0.2% | −63−0.4% | Reduced | Holders |
| Q2 2024 | 14,570 | $2.50M | 0.2% | −335−2.2% | Reduced | Holders |
| Q1 2024 | 14,905 | $2.71M | 0.2% | −2,707−15.4% | Reduced | Holders |
| Q4 2023 | 17,612 | $2.73M | 0.3% | −371−2.1% | Reduced | Holders |
| Q3 2023 | 17,983 | $2.68M | 0.3% | +3,197+21.6% | Added | Holders |
| Q2 2023 | 14,786 | $1.99M | 0.2% | +494+3.5% | Added | Holders |
| Q1 2023 | 14,292 | $2.28M | 0.2% | +49+0.3% | Added | Holders |
| Q4 2022 | 14,243 | $2.30M | 0.3% | −630−4.2% | Reduced | Holders |
| Q3 2022 | 14,873 | $2.00M | 0.3% | −55−0.4% | Reduced | Holders |
| Q2 2022 | 14,928 | $2.29M | 0.3% | −2,082−12.2% | Reduced | Holders |
| Q1 2022 | 17,010 | $2.76M | 0.3% | +1,822+12.0% | Added | Holders |
| Q4 2021 | 15,188 | $2.06M | 0.2% | +49+0.3% | Added | Holders |
| Q3 2021 | 15,139 | $1.63M | 0.2% | +61+0.4% | Added | Holders |
| Q2 2021 | 15,078 | $1.70M | 0.2% | −26−0.2% | Reduced | Holders |
| Q1 2021 | 15,104 | $1.64M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.